Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
The Journal of Allergy and Clinical Immunology|February 25, 2023
Lung dopaminergic nerves facilitate the establishment of TH2 resident memory cells in early lifeWei Wang, Carolyn Garcia, Fengzhi Shao, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 25, 2005
Bleomycin initiates apoptosis of lung epithelial cells by ROS but not by Fas/FasL pathwayShulamit B Wallach-Dayan, Gabriel Izbicki, Pazit Y Cohen, et al.
Circulation Research|November 5, 2005
Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cellsFrédéric Mouquet, Otmar Pfister, Mohit Jain, et al.
Neuron|November 23, 2006
State-dependent mechanisms of LTP expression revealed by optical quantal analysisBonnie Ward, Lindsay McGuinness, Colin J Akerman, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|October 12, 2002
Bleomycin-induced lung fibrosis in IL-4-overexpressing and knockout miceGabriel Izbicki, Reuven Or, Thomas G Christensen, et al.
Circulation Research|June 11, 2005
CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiationOtmar Pfister, Frédéric Mouquet, Mohit Jain, et al.
The Journal of Biological Chemistry|May 4, 2011
Activation dynamics and signaling properties of Notch3 receptor in the developing pulmonary arteryShamik Ghosh, Jesus R Paez-Cortez, Karthik Boppidi, et al.
JCI Insight|August 24, 2018
Retinoic acid signaling is essential for airway smooth muscle homeostasisFelicia Chen, Fengzhi Shao, Anne Hinds, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 14, 2013
An NT4/TrkB-dependent increase in innervation links early-life allergen exposure to persistent airway hyperreactivityLinh Aven, Jesus Paez-Cortez, Rebecca Achey, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|August 13, 2009
Launching invasive, first-in-human trials against Parkinson's disease: ethical considerationsJonathan Kimmelman, Alex John London, Bernard Ravina, et al.
Pageof 13